Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Plasticity-Based and Adaptive Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya

NCT02141022 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT02141022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Plasticity-Based and Adaptive Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
Lead sponsor
Stony Brook University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
September 30, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficits, gilenya modifying therapy for ms, multiple sclerosis